drugset / Trial / NCT02496013

Clinical Translation of a Novel Albumin-Binding PET Radiotracer 68Ga-NEB

NCT02496013 ↗

NaSingle-groupOpen-labelDiagnostic

Summary

This is an open-label whole-body PET/CT study for investigation of radiation dosimetry, plasma pharmacokinetics, biodistribution, safety and diagnostic performance of 68Ga-NEB in healthy volunteers and patients with suspected infection. Changes of routine blood and urine tests and any adverse events will be collected from the volunteers. Adverse events will also be observed in the patients.

Timeline

Start
2014-01
Primary completion
2017-12
Completion
2017-12

Drugs

EvaluationDrugModalityDoseRoute
Subject 68Ga-NEB Diagnostic / imaging agent 10 mbq Intravenous
Subject 68Ga-NEB Diagnostic / imaging agent 20 mbq Intravenous
Subject 68Ga-NEB Diagnostic / imaging agent 111 mbq Intravenous
Subject 68Ga-NEB Diagnostic / imaging agent 148 mbq Intravenous